Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may result in the double vision. Thyroid eye disease also known as Graves’ Orbitopathy or Ophthalmopathy which is an autoimmune condition, this condition often affects thyroid gland and makes it hyperactive in most of the cases. The thyroid eye disease can affect anybody whose thyroid gland is overactive or underactive or even functioning normally. Around 25% of people with graves’ disease can develop thyroid eye disease.
This report contains market size and forecasts of Thyroid Eye Disease Treatments in Global, including the following market information:
Global Thyroid Eye Disease Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Thyroid Eye Disease Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thyroid Eye Disease Treatments include Bausch And Lomb Inc, Kala Pharmaceuticals Inc, Pharmos Corp, Hi-Tech Pharmacal Co Inc, Allergan plc, Novartis AG, Eyevance Pharmaceuticals LLC, Pfizer Inc and Horizon Therapeutics plc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thyroid Eye Disease Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thyroid Eye Disease Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Thyroid Eye Disease Treatments Market Segment Percentages, by Type, 2021 (%)
Medication
Radioactive Iodine Therapy
Surgery
Global Thyroid Eye Disease Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Thyroid Eye Disease Treatments Market Segment Percentages, by Application, 2021 (%)
Surgery Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Thyroid Eye Disease Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Thyroid Eye Disease Treatments Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thyroid Eye Disease Treatments revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Thyroid Eye Disease Treatments revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch And Lomb Inc
Kala Pharmaceuticals Inc
Pharmos Corp
Hi-Tech Pharmacal Co Inc
Allergan plc
Novartis AG
Eyevance Pharmaceuticals LLC
Pfizer Inc
Horizon Therapeutics plc